These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 12387512)

  • 21. The effects of metformin in type 1 diabetes mellitus.
    Beysel S; Unsal IO; Kizilgul M; Caliskan M; Ucan B; Cakal E
    BMC Endocr Disord; 2018 Jan; 18(1):1. PubMed ID: 29338714
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Addition of neutral protamine lispro insulin or insulin glargine to oral type 2 diabetes regimens for patients with suboptimal glycemic control: a randomized trial.
    Esposito K; Ciotola M; Maiorino MI; Gualdiero R; Schisano B; Ceriello A; Beneduce F; Feola G; Giugliano D
    Ann Intern Med; 2008 Oct; 149(8):531-9. PubMed ID: 18936501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.
    Derosa G; D'Angelo A; Fogari E; Salvadeo S; Gravina A; Ferrari I; Cicero AF
    J Clin Pharm Ther; 2009 Feb; 34(1):13-23. PubMed ID: 19125899
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
    Kvapil M; Swatko A; Hilberg C; Shestakova M
    Diabetes Obes Metab; 2006 Jan; 8(1):39-48. PubMed ID: 16367881
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The addition of metformin in type 1 diabetes improves insulin sensitivity, diabetic control, body composition and patient well-being.
    Moon RJ; Bascombe LA; Holt RI
    Diabetes Obes Metab; 2007 Jan; 9(1):143-5. PubMed ID: 17199734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low-dose metformin improves hyperglycaemia related to myotonic dystrophy.
    Kouki T; Takasu N; Nakachi A; Tamanaha T; Komiya I; Tawata M
    Diabet Med; 2005 Mar; 22(3):346-7. PubMed ID: 15717887
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glycemic control with metformin or insulin therapy in adolescents with type 2 diabetes mellitus.
    Kadmon PM; Gruppuso PA
    J Pediatr Endocrinol Metab; 2004 Sep; 17(9):1185-93. PubMed ID: 15506677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus.
    Kooy A; de Jager J; Lehert P; Bets D; Wulffelé MG; Donker AJ; Stehouwer CD
    Arch Intern Med; 2009 Mar; 169(6):616-25. PubMed ID: 19307526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sitagliptin as add-on therapy in insulin deficiency: biomarkers of therapeutic efficacy respond differently in type 1 and type 2 diabetes.
    Giampietro O; Giampietro C; Bartola LD; Masoni MC; Matteucci E
    Drug Des Devel Ther; 2013; 7():99-104. PubMed ID: 23439744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of patient education on KAP, medication adherence and therapeutic outcomes of metformin versus insulin therapy in patients with gestational diabetes: A Hospital based pilot study in South India.
    Krishnakumar S; Govindarajulu Y; Vishwanath U; Nagasubramanian VR; Palani T
    Diabetes Metab Syndr; 2020; 14(5):1379-1383. PubMed ID: 32755838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients.
    Poulsen MK; Henriksen JE; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 2003 Dec; 26(12):3273-9. PubMed ID: 14633813
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of adding metformin to insulin therapy for type 1 diabetes mellitus children: A systematic review and meta-analysis.
    Al Khalifah RA; Alnhdi A; Alghar H; Alanazi M; Florez ID
    Pediatr Diabetes; 2017 Nov; 18(7):664-673. PubMed ID: 28145083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Glycemic control and treatment failure with pioglitazone versus glibenclamide in type 2 diabetes mellitus: a 42-month, open-label, observational, primary care study.
    Hanefeld M; Pfützner A; Forst T; Lübben G
    Curr Med Res Opin; 2006 Jun; 22(6):1211-5. PubMed ID: 16846554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes care, glycemic control, and complications in children with type 1 diabetes from Asia and the Western Pacific Region.
    Craig ME; Jones TW; Silink M; Ping YJ
    J Diabetes Complications; 2007; 21(5):280-7. PubMed ID: 17825751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidiabetic prescriptions and glycemic control in German patients with type 2 diabetes mellitus: a retrospective database study.
    Yurgin N; Secnik K; Lage MJ
    Clin Ther; 2007 Feb; 29(2):316-25. PubMed ID: 17472823
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Persistent differences among centers over 3 years in glycemic control and hypoglycemia in a study of 3,805 children and adolescents with type 1 diabetes from the Hvidøre Study Group.
    Danne T; Mortensen HB; Hougaard P; Lynggaard H; Aanstoot HJ; Chiarelli F; Daneman D; Dorchy H; Garandeau P; Greene SA; Hoey H; Holl RW; Kaprio EA; Kocova M; Martul P; Matsuura N; Robertson KJ; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J;
    Diabetes Care; 2001 Aug; 24(8):1342-7. PubMed ID: 11473067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Triple therapy in type 2 diabetes: insulin glargine or rosiglitazone added to combination therapy of sulfonylurea plus metformin in insulin-naive patients.
    Rosenstock J; Sugimoto D; Strange P; Stewart JA; Soltes-Rak E; Dailey G
    Diabetes Care; 2006 Mar; 29(3):554-9. PubMed ID: 16505505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum leptin concentrations in children with type 1 diabetes mellitus: relationship to body mass index, insulin dose, and glycemic control.
    Soliman AT; Omar M; Assem HM; Nasr IS; Rizk MM; El Matary W; El Alaily RK
    Metabolism; 2002 Mar; 51(3):292-6. PubMed ID: 11887162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.